Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by G. D. Laverman
ACE Inhibition Versus Angiotensin Receptor Blockade: Which Is Better for Renal and Cardiovascular Protection?
Journal of the American Society of Nephrology : JASN
Medicine
Nephrology
Related publications
Angiotensin-Converting Enzyme Inhibitors (ACE-Is) Versus Angiotensin- Receptor Blockers (ARBs): Any Superiority?
Journal of Hypertension- Open Access
Dual Blockade of the Renin-Angiotensin System With Angiotensin Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARBs)
British Journal of Clinical Pharmacology
Pharmacology
Effects of Renal Denervation on Cardiovascular and Renal Responses to ACE Inhibition in Conscious Lambs
Journal of Applied Physiology
Medicine
Physiology
Sports Science
P3.01-115 Liposomal Paclitaxel Versus Gemcitabine: Which Is Better?
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Angiotensin II Receptor Blockade and Ventricular Remodelling
JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal Medicine
Endocrinology
Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy
Journal of the American Society of Nephrology : JASN
Medicine
Nephrology
Angiotensin 2 Type 2 Receptor Blockade Is a Novel Target for Murine Osteoarthritis Pain
Osteoarthritis and Cartilage
Sports Medicine
Rheumatology
Orthopedics
Biomedical Engineering
Angiotensin Receptor Blocker Protection Against Podocyte-Induced Sclerosis Is Podocyte Angiotensin II Type 1 Receptor-Independent
Hypertension
Internal Medicine
Angiotensin-Converting Enzyme Inhibition Potentiates Angiotensin II Type 1 Receptor Effects on Renal Bradykinin and cGMP
Hypertension
Internal Medicine